Keros Therapeutics (KROS) Other financing activities (2019 - 2025)
Keros Therapeutics (KROS) posted Other financing activities of $115000.0 for Q4 2025, up 5650.0% on a QoQ basis from $2000.0 in Q3 2025, and down 95.3% year-over-year from $2.4 million in Q4 2024.
Keros Therapeutics (KROS) Other financing activities (2019 - 2025) Analysis & Trends
Keros Therapeutics' Other financing activities history runs 7 years deep, the most recent figure standing at $115000.0 for Q4 2025.
- Quarterly Other financing activities fell 95.3% year-over-year to $115000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $138000.0 (down 98.86% YoY) and the FY2025 annual result came in at $138000.0, down 98.86% from the prior year.
- Other financing activities was $115000.0 for Q4 2025 at Keros Therapeutics, up from $2000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $5.7 million in Q1 2024 and bottomed at $2000.0 in Q3 2025.
- A 5-year average of $835050.0 and a median of $181500.0 in 2021 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2021 — Other financing activities slumped 99.94% — and 2024, when it surged 1446.22%.
- Keros Therapeutics' Other financing activities stood at $245000.0 in 2021, then tumbled by 58.37% to $102000.0 in 2022, then jumped by 688.24% to $804000.0 in 2023, then jumped by 204.1% to $2.4 million in 2024, then slumped by 95.3% to $115000.0 in 2025.
- Business Quant data shows KROS's Other financing activities at $115000.0 in Q4 2025, $2000.0 in Q3 2025, and $17000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Keros Therapeutics | 374.82 Mn | 87.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 115,000.00 |
| Dec 31, 2025 | 115,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 2.45 Mn |
| Dec 31, 2024 | 2.45 Mn |
| Sep 30, 2024 | 1.01 Mn |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 2.97 Mn |
| Jun 30, 2024 | 2.97 Mn |
| Mar 31, 2024 | 5.72 Mn |
| Mar 31, 2024 | 5.72 Mn |
| Dec 31, 2023 | 804,000.00 |
| Dec 31, 2023 | 804,000.00 |
| Sep 30, 2023 | 311,000.00 |
| Sep 30, 2023 | 311,000.00 |